At the IGTP TODAY
A collaborative study led by researchers from IGTP has revealed the promising possibilities of using an agarose spot migration assay to examine the ability of extracellular vesicles to attract other cells in a controlled environment. The study has been recently published in the journal BMC Biology.
The podcast from the Germans Trias i Pujol Research Institute (IGTP) launches a new episode titled "Stroke: a race against the clock"). Researcher and clinician Mònica Millán explains what everyone should know about this pathology, as well as the research her group is conducting to improve the lives of patients.
On 23 October, the "Translational research and innovation through EATRIS" workshop was held at IGTP. The purpose of this event was to discuss the advances and perspectives of EATRIS both in Spain and in Europe, highlighting the research and innovation activity of the IGTP.
The research, led by Cima Universidad de Navarra, sheds light on new possibilities for addressing various types of cancer. This work has been carried out in collaboration with Dr Carolina Armengol, leader of IGTP’s Childhood Liver Oncology (C-LOG) group, a pioneer in the study of childhood liver cancer in Spain.
The first urine test that detects kidney fibrosis as an alternative to kidney biopsies, an initiative from the IVECAT group, and a project applying artificial intelligence to rapidly categorise stroke patients and enhance their recovery chances, from the Neurovascular Research group, are two of the fifteen projects from Catalan research centres selected within the 2023 call of the new CaixaImpulse Healthcare Innovation programme.
An article published in Nature Communications on the pilot study carried out in Catalonia to evaluate the self-collection of biological samples reveals the high acceptability of the proposal and the key role of diagnosis in people without symptoms of mpox.
A study has identified a molecule that could potentially be a target for the development of immunotherapies, led by IrsiCaixa AIDS Research Institute and spearheaded by Julia García-Prado, principal investigator at the same centre and scientific director of the Germans Trias i Pujol Research Institute (IGTP).
The collaborative project InMaM, part of the Complementary Plan for Biotechnology Applied to Health, involving both Catalonia and the Basque Country, aims to discover new immunotherapy-based treatments for metastatic breast cancer.
A study co-led by researchers from IGTP, IIB Sant Pau and IDIBGI concludes that direct transport to a referral centre for endovascular treatment may not be the best option for patients with a final diagnosis of intracerebral haemorrhage or haemorrhagic stroke.
